Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY
Benzinga Newsdesk 1 year ago
EarningsNews
Protagenic Therapeutics (NASDAQ:PTIX) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.
Protagenic Therapeutics (NASDAQ:PTIX) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.